Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia
CONCLUSIONS: In Saudi Arabia, Pfizer/BioNTech and Oxford/AstraZeneca vaccinations significantly reduced the number of SARS-CoV-2 cases and deaths after the vaccination compared to the period before the vaccination campaign at country levels. The study findings demonstrate that vaccination and adherence to nonpharmaceutical intervention can better control the COVID-19 pandemic.PMID:34859883 | DOI:10.26355/eurrev_202111_27271
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Authors: S A Meo F Fahad Al-Jassir S Al-Qahtani R Albarrak A M Usmani D C Klonoff Source Type: research
More News: AstraZeneca | Coronavirus | COVID-19 | Drugs & Pharmacology | Epidemics | Epidemiology | Infectious Diseases | International Medicine & Public Health | Middle East Health | Pandemics | Pfizer | Respiratory Medicine | SARS | Saudi Arabia Health | Study | Vaccines | WHO